Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Oncology Institute (TOI) Interest & Investment Income (2020 - 2023)

Oncology Institute's Interest & Investment Income history spans 3 years, with the latest figure at $940000.0 for Q3 2023.

  • For Q3 2023, Interest & Investment Income changed N/A year-over-year to $940000.0; the TTM value through Sep 2023 reached $3.2 million, up 54763.75%, while the annual FY2020 figure was $254149.0, N/A changed from the prior year.
  • Interest & Investment Income reached $940000.0 in Q3 2023 per TOI's latest filing, down from $1.0 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.2 million in Q1 2023 to a low of $5798.0 in Q3 2021.
  • Average Interest & Investment Income over 3 years is $383437.7, with a median of $73393.0 recorded in 2020.
  • The largest YoY upside for Interest & Investment Income was 91.48% in 2021 against a maximum downside of 92.1% in 2021.
  • A 3-year view of Interest & Investment Income shows it stood at $59248.0 in 2020, then plummeted by 90.21% to $5798.0 in 2021, then surged by 16112.49% to $940000.0 in 2023.
  • Per Business Quant, the three most recent readings for TOI's Interest & Investment Income are $940000.0 (Q3 2023), $1.0 million (Q2 2023), and $1.2 million (Q1 2023).